The 5TMM series: a useful in vivo mouse model of human multiple myeloma.
Asosingh
K
K
Department of Hematology and Immunology, Free University Brussels (VUB), Laarbeeklaan 103, B-1090 Brussels, Belgium.
Radl
J
J
Van Riet
I
I
Van Camp
B
B
Vanderkerken
K
K
D000818:Animals; D019496:Cancer Vaccines; D002869:Chromosome Aberrations; D004195:Disease Models, Animal; D016259:Genes, myc; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D009101:Multiple Myeloma / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000517:prevention & control; D009194:Myeloma Proteins / Q000032:analysis; D010014:Osteolysis / Q000209:etiology; D010265:Paraproteinemias / Q000235:genetics / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000139:chemically induced; D010954:Plasmacytoma / Q000139:chemically induced; D013729:Terpenes / Q000633:toxicity; D014183:Transplantation, Heterologous; D014611:Vaccination; D019444:Vaccines, DNA
D019496:Cancer Vaccines; D009194:Myeloma Proteins; D013729:Terpenes; D019444:Vaccines, DNA; C009042:pristane